LEXYAL FINE

LEXYAL FINE is a cutting-edge dermal filler that utilizes crosslinked hyaluronic acid technology. It is specifically designed for mid-to-deep dermal implantation, making it suitable for correcting facial wrinkles, enhancing contours, and restoring volume in various areas of the face. The product is characterized by its high elastic modulus and excellent cohesion, which contribute to its effectiveness in aesthetic 

Key Features

1. CE Certification: LEXYAL FINE holds a CE certificate, indicating that it meets European health and safety standards.
2. HA Gel By Pnet: This refers to the advanced technology used in creating the hyaluronic acid gel, ensuring superior results.
3. Zero Endotoxin: The product guarantees a safe formulation with endotoxin levels significantly below standard requirements.
4. Lower MoD (Modification Degree): This feature ensures minimal alteration during the treatment process, resulting in a more natural appearance post-application.
5. Advanced Monophasic Filler: LEXYAL FINE offers consistent and smooth application while providing long-lasting effects.
6. Using Water For Injection: The filler uses high-purity water for optimal biocompatibility and reduced side effects.

Application Areas

LEXYAL FINE is particularly effective for treating various facial concerns:

• Superficial Wrinkles: It helps smooth out fine lines on the skin’s surface, providing a refreshed look.
• Periorbital Lines: Targets wrinkles around the eyes, such as crow’s feet.
• Glabellar Lines: Reduces frown lines located between the eyebrows.
• Worry Lines: Minimizes horizontal lines on the forehead that can create an aged appearance.
• Lobule Enhancements: Improves the aesthetic appearance of earlobes.
• Perioral Lines: Smooths fine lines around the mouth area to enhance smiles.

Product Specifications

LEXYAL FINE comes in a 1 mL syringe containing cross-linked hyaluronic acid gel at a concentration of 24 mg/mL. The product is sterilized using moist heat and packaged with a hypodermic needle that has been sterilized using ethylene oxide.

A pre-clinical evaluation conducted over one year indicated that LEXYAL remains implanted in human skin tissues for at least six months and is considered biodegradable within one year after implantation.